Pfizer Archives - The Ohio Star

Not One State Reported a Sizable Increase in Coronavirus Cases Last Week

May 15, 2021May 14, 2021 Ohio Star Staff

For the first time in months, not one state reported a dramatic weekly increase in coronavirus cases.

While average daily cases fell by less than 10% in 11 states, 37 states saw cases fall by over 10% and just two states had cases marginally increase, according to data from Johns Hopkins University. The United States also averaged fewer than 40,000 daily cases last week, a 21% drop from the week prior and the lowest total since September.

Death and hospitalization rates have also plummeted nationwide. The U.S. has averaged 600 deaths per day, the lowest point in approximately 10 months. If the number continues to fall the nation could soon hit its lowest point of the entire pandemic, according to the Associated Press.

Pfizer: Israeli Data Finds Vaccine Prevents 94 Percent of Asymptomatic Infections

March 22, 2021March 21, 2021 Ohio Star Staff

Pfizer’s coronavirus vaccine was over 94% effective in preventing asymptomatic cases of COVID-19, according to real-world Israeli data released late Thursday.

The latest analysis suggests that Pfizer’s vaccine could overwhelmingly halt asymptomatic spread — a main driver of infections since asymptomatic people are often unaware they have the virus. The data also showed that the vaccine was 97% effective in preventing symptomatic cases, hospitalizations and deaths, slightly higher than the 95% effectiveness found in its clinical trials.

Pfizer Says Its Vaccine Significantly Halts COVID-19’s Spread, Effective Against UK Variant

March 13, 2021March 12, 2021 Ohio Star Staff

Pfizer said Wednesday that real-world data suggests its coronavirus vaccine is 94% effective in halting asymptomatic infections and effective against a highly transmissible variant first discovered in the United Kingdom.

Israeli analysis of vaccine distribution shows the vaccine being over 97% effective in preventing symptomatic cases and death, higher than the 90% efficiency that was reported in the vaccine’s Phase III trials, Pfizer said in a press release Thursday. Over 80% of the tested specimens were against the UK variant known as B.1.1.7.

Pfizer Vaccine Is Effective Against Fast-Spreading Brazilian Coronavirus Variant, Study Shows

March 10, 2021March 9, 2021 Ohio Star Staff

Pfizer’s coronavirus vaccine was able to neutralize the highly transmissible Brazilian virus variant, a new lab study showed.

The effectiveness of the vaccine against the variant was “roughly equivalent” to the original strain, researchers told the New England Journal of Medicine. Its ability to combat the variant, known as P.1, is especially encouraging in Brazil, where it has spread throughout the country.

Pfizer, Moderna Vaccines May Offer Less Protection Against South African Coronavirus Variant

February 20, 2021February 19, 2021 Ohio Star Staff

Recent studies indicate that the Pfizer and Moderna coronavirus vaccines may have reduced protection against the South African coronavirus strain, according to reports in the New England Journal of Medicine, raising concerns that they could be less effective against future mutations.

Though both vaccines appeared to generate enough antibodies to neutralize the mutant strain, they both produced fewer antibodies when compared to the original virus. But experts warned that it was unclear just how much protection was needed to neutralize the variant, which scientists believe is more contagious than the original strain.

Pfizer Vaccine Effective Against Contagious Coronavirus Strain, Study Shows

January 9, 2021January 8, 2021 Ohio Star Staff

The vaccine developed by Pfizer and BioNTech protects against a highly contagious strain of coronavirus that originated in South Africa and the U.K., according to a study published Thursday.

The study, which was commissioned by Pfizer, is likely to alleviate some fears that the virus variant would evade protections offered by the vaccine.

Pfizer, U.S. Reach Deal for 100 Million Additional Coronavirus Vaccine Doses

December 24, 2020December 23, 2020 Ohio Star Staff

The Trump Administration has purchased an additional 100 million doses of Pfizer’s coronavirus vaccine, the drugmaker announced Wednesday.

The new agreement means that Pfizer will supply 200 million doses to the United States, according to the company’s statement, which will be distributed through July 2021. Also included in the deal is the option to purchase an additional 400 million doses.

Commentary: We Had the Vaccine from the Start—You Just Weren’t Allowed to Take It

December 23, 2020December 22, 2020 Ohio Star Staff

Few people realize that the Moderna vaccine against COVID-19—which the FDA has finally declared “highly effective,” and which is now being distributed to Americans—has actually been available for nearly a year.

But the government wouldn’t let you take it.

Coronavirus Vaccines Can Guard Against New, More Contagious UK Strain, Experts Say

December 22, 2020December 21, 2020 Admin

The two coronavirus vaccines that have been approved for emergency use authorization in the U.S. will be able to combat a new, more contagious strain of the virus in the U.K., experts said Monday.

Vaccines made by pharmaceutical companies Pfizer and Moderna will be effective against the new strain, which is “very similar” to previous strains at the genetic level, University of Washington’s Institute for Health Metrics and Evaluation affiliate assistant professor Vin Gupta told CNBC. The Food and Drug Administration has approved both vaccines for emergency use authorization after large-scale human trials showed efficacy of more than 90%.

Tennessee Nurse Who Fainted After Receiving COVID-19 Vaccine Says It Was Due to Underlying Condition

December 22, 2020December 21, 2020 Corinne Murdock

The nurse who appeared to faint after receiving a COVID-19 vaccine in a viral video has recovered, according to a statement issued by her employer. Tiffany Dover, a nurse at CHI Memorial Hospital, reportedly came close to passing out due to a medical condition unrelated to the vaccination.

The hospital also cited information from the Centers for Disease Control (CDC) website, which stated that fainting sometimes occurs after all types of vaccinations.

Pfizer Vaccine Vials Contain More Doses Than Expected, FDA Says

December 18, 2020December 17, 2020 Ohio Star Staff

Some vials containing Pfizer’s coronavirus vaccine contain more doses than expected, potentially expanding the country’s supply by up to 40%, public health officials said late Wednesday.

The FDA advised that the extra doses were acceptable to use and that it was collaborating with Pfizer over the issue.

Ohio Gov. DeWine, Who Owns Pfizer Stock, Has Received $22,700 in Contributions from the Drug Company Since 2018

December 17, 2020December 16, 2020 Jack Windsor

Governor DeWine unexpectedly called a press conference on Monday. It was the day the Pfizer vaccine arrived in Ohio and DeWine called it “historic,” our “hope” and the “beginning of the end” of COVID. A video of he and First Lady Fran DeWine can be viewed below as the…

US Wants to Double COVID-19 Vaccine Order from Pfizer

December 15, 2020December 14, 2020 Ohio Star Staff

Pfizer CEO Albert Bourla said on CNN Monday that the U.S. is seeking to double its COVID-19 vaccine order.

“So far, we have an agreement with the U.S. Government to provide them 100 million doses and this is a fixed order and we will provide those 100 million doses starting from now by the end of the first quarter and we will honor this commitment,” Bourla told CNN Chief Medical Correspondent Dr. Sanjay Gupta on “New Day With Alisyn Camerota and John Berman.”

Trucks Carrying COVID-19 Vaccine Roll Out from Michigan Pfizer Plant

December 14, 2020December 13, 2020 Ohio Star Staff

Video footage showed the first shipment of the coronavirus vaccine leaving Pfizer’s Michigan location on Sunday.

UPS, Boyle and FedEx trucks were captured on video leaving the facility located close to Kalamazoo, Michigan.

Three Ohio Cities Rank High Among Cities Needing the Most COVID-19 Vaccines

December 13, 2020December 12, 2020 The Center Square

With COVID-19 vaccines expected in states throughout the country next week, some communities need more than others, according to a recently released study, and Ohio is home to three of those cities.

According to the personal finance website WalletHub, Cleveland, Toledo and Cincinnati rank among the top 10 of 90 large cities in the United States in terms of vaccine need based on 13 key factors, such as frontline healthcare workers, nursing home residents, essential workers, residents diagnosed with various diseases and other things.

First Person Receives Pfizer’s Vaccine as Britain Begins Mass Coronavirus Vaccination Effort

December 9, 2020December 8, 2020 Ohio Star Staff

Britain’s National Health Service administered its first doses of a coronavirus vaccine Tuesday, becoming the first country to begin its mass vaccination effort.

Just after 6:30 a.m. Tuesday, 90-year-old Margaret Keenan became the first person to receive a fully authorized vaccine outside of a clinical trial, marking the beginning of a global campaign to end a pandemic that has infected over 65 million people and killed over 1.5 million across the globe.

CDC Committee to Discuss COVID-19 Vaccine Next Week

November 29, 2020November 28, 2020 The Center Square

The group of medical and public health experts that develops recommendations for vaccine use for the Centers for Disease and Prevention (CDC) will meet Tuesday.

CDC’s Advisory Committee on Immunization Practices (ACIP) posted a notice for a meeting scheduled for Dec. 1 without any details, but officials confirmed Friday that COVID-19 vaccination would be on the agenda.

COVID-19 Vaccine Temperature Requirements Could Create Logistics Challenge

November 24, 2020November 23, 2020 The Center Square

Many states in the U.S. are hinging their COVID-19 mitigation strategies on the availability of a widely available vaccine. An issue bound to arise is the extremely cold temperatures the most promising experimental vaccines need to be kept at and the logistics of delivering them across the country.

Moderna’s COVID-19 vaccine is estimated to remain stable at standard refrigerator temperatures of 36° to 46°F for 30 days. Longer storage means a required temperature of mRNA-1273 needs -4°F for up to six months.

Pfizer: COVID-19 Shot 95 Percent Effective, Seeking Clearance Soon

November 19, 2020November 18, 2020 The Associated Press

Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe.

Pfizer Notified Biden Before Trump on Vaccine Success

November 13, 2020November 12, 2020 Ohio Star Staff

In an interview with WMAL radio show Wednesday morning, Health and Human Services Secretary Alex Azar appeared to confirm that the Trump administration learned of Pfizer’s successful COVID-19 vaccine trial from press coverage not from company officials directly. “I…learned of this from media reports on Monday morning,” Azar told “Mornings on the Mall” program on November 11. “There certainly was a gap in communications, let’s say.”

Gov. Mike DeWine Re-Imposes Statewide Mandatory Mask Mandate

November 13, 2020November 12, 2020 Jack Windsor

COLUMBUS, Ohio – Governor Mike DeWine made time during Wednesday night’s special broadcast to laud Pfizer and their progress on a coronavirus vaccine before effectively re-instating a mandatory mask mandate across the state. “On Monday, our country received some very promising news regarding a Coronavirus vaccine that Pfizer is…

Commentary: Was Pfizer’s Vaccine News Slow-Walked Until After the Election?

November 11, 2020November 10, 2020 Ohio Star Staff

As the coronavirus pandemic swept across the globe in the spring, President Trump announced his plan to fast-track an effective vaccine that would be available by the new year.

The goal of Operation Warp Speed, launched by the White House in May, was “to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.” Congress appropriated $10 billion to fund the ambitious program.

U.S. Will Pay $1.95 Billion for 100 Million Doses of Coronavirus Vaccine Doses

July 23, 2020July 22, 2020 Ohio Star Staff

The federal government pledged $1.95 billion for an order of 100 million doses, with an option to acquire an additional 500 million doses of a coronavirus vaccine, which is set to enter key large-scale trials in the coming weeks.